Intensity Therapeutics, Inc.
INTS
$1.85
-$0.01-0.54%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 9.45% | 29.33% | -7.99% | -45.11% | -36.20% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 70.10% | -13.74% | -48.58% | 170.63% | 21.53% |
| Change in Net Operating Assets | 62.73% | -708.75% | 117.32% | -151.42% | 157.17% |
| Cash from Operations | 32.83% | 5.74% | 3.48% | -361.52% | 81.52% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | 51,766.67% | -100.18% | 15.56% | 131.90% |
| Cash from Investing | -100.00% | 51,766.67% | -100.18% | 15.56% | 131.90% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 515.56% | 16,400.00% | -62.50% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -596.34% | -- | -- | -- | 100.00% |
| Cash from Financing | 499.52% | 13,666.67% | -62.50% | 161.54% | -100.06% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 58.17% | 89.12% | -284.06% | -158.97% | -71.61% |